Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Selective Acylation. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Advanced catalytic hydrogenation process for high-purity 2-amino-4-acetamidoanisole. Reduces waste and improves yield for disperse dye manufacturing.
Patent CN103265616A details a green, cost-effective synthesis of N(2)-L-alanyl-L-glutamine using aqueous acylation and stereoselective hydrogenation, offering significant supply chain advantages.
Novel chelation-based route for Amikacin from Kanamycin A eliminates corrosive silanes, offering high purity and cost-effective manufacturing for global supply chains.
Patent CN113683496A details a novel synthetic route for Agrimonol B and Pseudoaspidinol, offering cost reduction in API manufacturing through safer reagents and higher yields.
Patent CN103228639A reveals a novel selective acyl cleavage route for Dronedarone, offering superior purity and scalable manufacturing for cardiovascular API supply chains.
Patent CN105348132A details a low-waste synthesis route for 2-amino-4-acetamino anisole. Offers high purity, reduced environmental impact, and scalable manufacturing for dye intermediates.
Patent CN108676048B reveals a novel adenosine-based route for cordycepin. Achieve high purity and cost reduction in nucleoside manufacturing with scalable catalytic transfer hydrogenation.
Efficient regioselective synthesis method for sugar derivatives enabling cost reduction in pharmaceutical intermediates manufacturing and supply chain reliability.
Patent CN104370932A details a selective acylation method for pyripyropene derivatives, offering cost reduction in agrochemical intermediate manufacturing and high-purity supply chain solutions.
Patent CN101274923B reveals a novel nitrate-catalyzed method for selective acylation, offering significant cost reduction in API manufacturing and enhanced supply chain reliability.
Patent CN108314689A details a regioselective synthesis for 4,11-diacyl bergenin. This method offers significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Explore CN1108653A technology for synthesizing hyper-potent paclitaxel analogs. Offers superior solubility and antitumor activity for reliable API intermediate supply chains.
Patent CN102348706A details a novel selective acylation method for pyripyropene derivatives, offering significant cost reduction and improved purity for agrochemical manufacturing.
Novel regioselective acylation method improves yield and purity for temsirolimus production, offering supply chain stability and cost efficiency for global buyers.
Patent CN114560894B reveals a novel two-step route to Molnupiravir using Lewis acid catalysis, offering significant cost reduction in pharmaceutical manufacturing and enhanced supply chain reliability.
Novel DMF-based synthesis reduces waste and improves safety for dye intermediate manufacturing supply chains with high purity.